Despite these challenges, the potential benefits of recombinant therapeutic antibodies and proteins are significant. These molecules have the potential to revolutionize the way we treat diseases, and could provide new treatment options for patients who have been unsuccessful with traditional treatments. As research in this field continues to advance, Recombinant Therapeutic Antibodies and Proteins likely that we will see the development of even more effective and targeted therapies in the future.
Recombinant DNA technology is used to create recombinant protein therapies. This process involves inserting the DNA encoding the protein into bacterial or mammalian cells, allowing the cells to express the protein, and then purifying the protein from the cells. Many biologics are recombinant protein treatments, including monoclonal antibodies.
